Canaccord Genuity Reiterates a 'Buy' on Trius Therapeutics (TSRX); Insider Plan Triggers Share Distribution

Go back to Canaccord Genuity Reiterates a 'Buy' on Trius Therapeutics (TSRX); Insider Plan Triggers Share Distribution
TRIUS THERAPEUTICS (NASDAQ: TSRX) Delayed: 13.63 --0 (-0%)
Previous Close $13.63    52 Week High $14.17 
Open $13.63    52 Week Low $4.41 
Day High $13.63    P/E N/A 
Day Low $13.63    EPS $-1.61 
Volume 91,764